Image 1
Norethindrone Acetate Tablet
Product Images NDC 0555-0211
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate (NDC 0555-0211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Not available.*
Image 3
This is a patient information leaflet for Norethindrone Acetate Tablets USP, which is an orally-active progestin medication. The leaflet provides instructions for storage and emphasizes that the medication should be kept out of the reach of children. The medication is produced by Teva Pharmaceuticals USA, Inc. The lot number and expiration date are given, but there is no readable information about the recommended usage or potential side effects of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
